Hematology Oncology of Indiana — Indianapolis, Indiana

Hematology Oncology of Indiana is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Hematology Oncology of Indiana has participated in 6 clinical trials.

Therapeutic areas: Breast Cancer, Pancreatic Cancer, Advanced Breast Cancer.

Sponsors: Novartis Pharmaceuticals, Puma Biotechnology, Inc., KangLaiTe USA.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology of Indiana?

Hematology Oncology of Indiana has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology of Indiana conducted?

Hematology Oncology of Indiana has 6 clinical trials on record. Their work covers Breast Cancer, Pancreatic Cancer, Advanced Breast Cancer.

Is Hematology Oncology of Indiana accredited by Crixeo Health?

Hematology Oncology of Indiana has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology Oncology of Indiana?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.